4/A
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-029049
Chief Medical Officer sold 36,912 shares at an average $25.44 ($938,976)
- Chief Medical Officer acquired 17,879 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-04-01 | Option exercise | +5,775 | $5.28 | $30,492 | 5,775 | D |
| Ho Carole Chief Medical Officer | 2019-04-01 | Sale | −5,775 | $23.91 | $138,080 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-04-02 | Option exercise | +6,242 | $5.28 | $32,958 | 6,242 | D |
| Ho Carole Chief Medical Officer | 2019-04-02 | Sale | −2,800 | $24.51 | $68,628 | 3,442 | D |
| Ho Carole Chief Medical Officer | 2019-04-02 | Sale | −3,442 | $25.15 | $86,566 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-04-02 | Sale | −9,445 | $25.29 | $238,864 | 132,670 | I |
| Ho Carole Chief Medical Officer | 2019-04-03 | Option exercise | +5,862 | $5.28 | $30,951 | 5,862 | D |
| Ho Carole Chief Medical Officer | 2019-04-03 | Sale | −5,262 | $26.27 | $138,233 | 600 | D |
| Ho Carole Chief Medical Officer | 2019-04-03 | Sale | −600 | $26.81 | $16,086 | 0 | D |
| Ho Carole Chief Medical Officer | 2019-04-03 | Sale | −8,688 | $26.29 | $228,408 | 123,982 | I |
| Ho Carole Chief Medical Officer | 2019-04-03 | Sale | −900 | $26.79 | $24,111 | 123,082 | I |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2019-04-01 | Option exercise · Stock Option (right to buy) | −5,775 | 105,855 | D | ||
| Ho Carole Chief Medical Officer | 2019-04-02 | Option exercise · Stock Option (right to buy) | −6,242 | 99,613 | D | ||
| Ho Carole Chief Medical Officer | 2019-04-03 | Option exercise · Stock Option (right to buy) | −5,862 | 93,751 | D | ||
| Open-market sales · 36,912 sh · avg $25.44 · $938,976 | |||||||
Loading xslF345X03/doc4a.xml…